Epsilon Healthcare Limited

EPN

AU0000137598

Pharmaceuticals

Market Closed - Australian S.E. Other stock markets 05:07:33 18/12/2023 am IST			5-day change	1st Jan Change
0.024 ^AUD	-.--%		-.--%	-.--%

2023	Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting	CI
2023	Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting	CI

Epsilon Healthcare Limited Announces Resignation of Dr. Rob Jenny as A Director

August 08, 2022 at 04:27 am IST

Epsilon Healthcare Limited advised that Dr. Rob Jenny has resigned as a director of the Company with effect from yesterday, 7 August 2022. Dr. Jenny has served as an Executive Director of the Company since August 2021 pursuant to an arrangement between the Company and Cannvalate Pty Ltd. (Cannvalate) as part of securing broader strategic alignment between them.

Latest news about Epsilon Healthcare Limited

Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting	20/12	CI
Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting	20/12	CI
Epsilon Healthcare Appoints Joint and Several Administrators	18/12	MT
Epsilon Healthcare Limited Provides Information to Shareholders	15/12	CI
Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd	01/12	CI
Epsilon Healthcare Limited Announces Board Appointments	01/12	CI
Epsilon Healthcare Provides Information to Shareholders	22/11	CI
Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer	21/11	CI
Epsilon Healthcare Issues Notice of Extraordinary General Meeting	21/11	CI
Epsilon Healthcare Limited Announces Change of Address, Effective 22 November 2023	21/11	CI
Epsilon Healthcare Limited Reports Earnings Results for the Half Year Ended June 30, 2023	31/23/31	CI
Epsilon Healthcare Rebrands Manufacturing, Telehealth Businesses	03/23/03	MT
Epsilon Healthcare Appoints CEO	19/23/19	MT
Epsilon Healthcare Appoints Peter Giannopoulos as Chief Executive Officer, Effective 23 May, 2023	19/23/19	CI
Healthcare, IT Rally Ends Australian Shares' Three-Day Losing Streak	12/23/12	MT
Epsilon Healthcare Jumps 25% After Subsidiary Renews Medicinal Cannabis Permit	12/23/12	MT
Epsilon Healthcare Limited Auditor Raises 'Going Concern' Doubt	31/23/31	CI
Epsilon Healthcare Limited Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28	CI
Epsilon Healthcare Limited Announces Executive Changes	23/22/23	CI
Epsilon Healthcare Limited Announces Company Secretary Changes	30/22/30	CI
Epsilon Healthcare Limited Appoints Mark Audet as Chief Financial Officer	30/22/30	CI
Epsilon Healthcare Limited Announces Change of Registered Office and Principal Place of Business	30/22/30	CI
Epsilon Healthcare Limited Announces Resignation of Simon Rowe as Director	04/22/04	CI
Epsilon Healthcare Limited Announces Board Changes	01/22/01	CI
Epsilon Healthcare Limited Announces Appointment of Josh Cui as Director	31/22/31	CI

Chart Epsilon Healthcare Limited

Duration

Period

More charts

Company Profile

Epsilon Healthcare Limited is an Australia-based global healthcare and pharmaceuticals company. The Company has a diversified and vertically integrated portfolio of assets, including healthcare and pharmaceutical contract development and manufacturing. The Companyâs segments include the manufacture and distribution of hydroponics equipment, materials and nutrients, and the development and delivery of medicinal cannabis. The Company owns medicinal cannabis assets, including the GMP cannabis manufacturing facility in the Southern Hemisphere (the Southport Facility) in Southport, Australia, and the Tetra Health clinic group. The Company also provides advisory services related to medicinal cannabis. The Companyâs subsidiaries include Dragon Vision Limited, Canndeo Pty Ltd, Canna Clinics Pty Ltd, THC Pharma Pty Ltd, Metra Holdings Pty Ltd, Tetra Pty Ltd, Medimar Pty Ltd and Demimar Pty Ltd.

Sector

Pharmaceuticals

Calendar

29/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
EPSILON HEALTHCARE LIMITED	-.--%	47.86L
ELI LILLY AND COMPANY	+40.73%	74TCr
NOVO NORDISK A/S	+32.83%	60TCr
JOHNSON & JOHNSON	-6.30%	35TCr
MERCK & CO., INC.	+15.15%	32TCr
ABBVIE INC.	+4.05%	28TCr
ASTRAZENECA PLC	+15.00%	24TCr
ROCHE HOLDING AG	-5.52%	21TCr
AMGEN INC.	+6.17%	16TCr
PFIZER, INC.	-0.45%	16TCr